NCT07279571

Brief Summary

This study seeks to understand how endometrial cancer patients get medical information about cancer care and their satisfaction with those health-seeking methods. It also assesses patient interest in using an artificial intelligence educational resource.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
22mo left

Started Jun 2026

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jun 2026Jun 2028

First Submitted

Initial submission to the registry

November 20, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 12, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

June 12, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 9, 2028

Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

12 months

First QC Date

November 20, 2025

Last Update Submit

June 12, 2026

Conditions

Endometrial Carcinoma

Outcome Measures

Primary Outcomes (2)

  • Patient Satisfaction Scores

    Patients will complete a survey to assess their satisfaction with using an AI chatbot for HPV vaccine counseling.

    Up to 1 year

  • HPV Vaccination Rate

    HPV vaccination rate for patients who received the HPV vaccine counseling with the AI-chatbot

    Up to 1 year

Secondary Outcomes (1)

  • Demographics of patients

    Up to 1 year

Study Arms (1)

Observational

Patients complete a survey on study.

Other: Non-Interventional Study

Interventions

Non-Interventional StudyOTHER

Non-interventional study

Also known as: Non-Interventional Observational Study, Noninterventional (Observational) Study
Observational

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of the LA General gynecologic oncology clinic with a biopsy-proven diagnosis of endometrial cancer.

You may qualify if:

  • Patient of the LA General gynecologic oncology clinic
  • Age 18 years or older
  • Previously obtained the HPV vaccination (initial chatbot evaluation)
  • Eligible for HPV vaccination (pilot intervention; age \<46)
  • Willing and able to provide informed consent

You may not qualify if:

  • Patients who do not speak English or Spanish
  • Patients who do not provide informed consent
  • HPV vaccination rate (Aim 2):
  • Patient of the LA General gynecologic oncology clinic
  • Age 18 years or older
  • Obtained the HPV vaccine
  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Los Angeles General Medical Center

Los Angeles, California, 90033, United States

RECRUITING

USC / Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States

RECRUITING

MeSH Terms

Conditions

Endometrial Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Xiaoyue M Guo

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 20, 2025

First Posted

December 12, 2025

Study Start

June 12, 2026

Primary Completion (Estimated)

June 9, 2027

Study Completion (Estimated)

June 9, 2028

Last Updated

June 16, 2026

Record last verified: 2026-06

Locations

US(2)